← Back to Search

Wearable device deployment for Cancer

N/A
Waitlist Available
Led By Jamie M Faro, PhD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-month and 3-months post-enrollment
Awards & highlights

Study Summary

This trial is testing the feasibility of using wearable devices and a smartphone app to increase physical activity in cancer survivors. The app will send notifications and reminders about being active, and participants will be able to track their progress. The study team will use surveys and interviews to assess the program and ways to improve it.

Eligible Conditions
  • Cancer
  • Cardiovascular Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-month and 3-months post-enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-month and 3-months post-enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of enrollment
Secondary outcome measures
1-Month Usability
3-Month Usability
Changes in objective physical activity
+4 more
Other outcome measures
Provider acceptability of wearable devices and preferences to receive data

Trial Design

1Treatment groups
Experimental Treatment
Group I: Wearable device deploymentExperimental Treatment1 Intervention
Participants will be enrolled in the experimental trial to receive Fitbits and a smartphone app.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Wearable device deployment
2023
N/A
~40

Find a Location

Who is running the clinical trial?

University of Massachusetts, WorcesterLead Sponsor
342 Previous Clinical Trials
976,579 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,636 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,834 Previous Clinical Trials
47,310,604 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it permissible for those over 75 to partake in this experiment?

"The eligibility criteria for this clinical trial dictate that participants must have reached the age of majority, but be no older than 100."

Answered by AI

What requirements must I meet to become an eligible participant in this trial?

"To be eligible for this clinical trial, patients must have heart-related conditions and fall between 18 to 100 years of age. The study is recruiting around 40 individuals in total."

Answered by AI

Are there any available vacancies for participants in this trial?

"As indicated on clinicaltrials.gov, the current recruitment for this medical trial has ceased. The initial posting of the study was published on June 15th 2022 and it last underwent an update 8 days prior to its conclusion. Despite not being able to join this investigation, there are 893 other studies open for patients at present time."

Answered by AI

Who else is applying?

What state do they live in?
Vermont
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Survivor mHealth: Wearable Devices in Cancer Survivors
Jamie Faro 2023. "Survivor mHealth: Wearable Devices in Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05417438.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top